Related Experiment Video
Updated: Aug 8, 2025

05:54
Real-Time Dynamic Navigation System for the Precise Quad-Zygomatic Implant Placement in a Patient with a Severely Atrophic Maxilla
Published on: October 18, 2021
1.9K
Esthetic Considerations In Minimally Invasive Orthognathic Surgery.
Sung Hoon Choo1, Robert S Glickman2, Thomas G Wiedemann3
1General Practice Residency, Kings County Hospital Center, Brooklyn, New York.
Summary
Graftless dental implant solutions offer predictable alternatives to traditional bone grafting for edentulism treatment. These techniques maximize existing bone, reducing treatment time and complications.
Area of Science:
- Dental Implantology
- Oral and Maxillofacial Surgery
- Regenerative Medicine
Background:
- Dental implant success traditionally relies on alveolar bone volume.
- Bone grafting is a common solution for severe alveolar bone loss but has drawbacks.
- Graftless solutions offer alternatives by utilizing existing bone structures.
Purpose of the Study:
- To discuss the rationale behind graftless implant solutions.
- To review data supporting graftless protocols as alternatives to bone grafting.
- To explore modern graftless techniques for treating edentulism.
Main Methods:
- Review of literature on graftless implant therapy.
- Discussion of techniques utilizing residual alveolar bone.
- Analysis of extra-alveolar bone utilization (e.g., zygomatic implants).
- Emphasis on advanced imaging and 3D printing for customized implants.
Main Results:
- Graftless solutions can provide predictable outcomes for implant therapy.
- Subperiosteal implants, tailored with 3D printing, adapt to patient anatomy.
- Zygomatic implants leverage extraoral bone for stable implant placement.
- These methods offer alternatives to lengthy and complex bone grafting procedures.
Conclusions:
- Graftless implant protocols present viable and predictable alternatives to bone grafting.
- Modern technologies enable individualized graftless solutions for complex cases.
- These approaches minimize treatment time and donor site morbidity associated with grafting.

